DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors
Authors:
Open Access
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 24 (6) , 866-875
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Gastrointestinal stromal tumorsVirchows Archiv, 2010
- DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal TumorsAmerican Journal of Surgical Pathology, 2009
- PKC‐theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumourHistopathology, 2009
- PDGFRA Immunostaining Can Help in the Diagnosis of Gastrointestinal Stromal TumorsAmerican Journal of Surgical Pathology, 2008
- Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostainingJournal of Clinical Pathology, 2008
- PKCθ expression in gastrointestinal stromal tumorLaboratory Investigation, 2006
- PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to ImatinibJournal of Clinical Oncology, 2005
- Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal of Cancer, 2004
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002